J. Goldman & CO LP Obs Eva Sa Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.05 - $14.25 $457,275 - $648,375	-45,500 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$11.82 - $14.48 $355,782 - $435,848	-30,100 Reduced 39.81%	45,500 $582,000
Q4 2018 Feb 14, 2019	BUY	$10.8 - $17.94 $65,610 - $108,985	6,075 Added 8.74%	75,600 $957,000
Q3 2018 Nov 14, 2018	SELL	$10.92 - $18.18 $496,587 - $826,735	-45,475 Reduced 39.54%	69,525 $1.25 Million
Q2 2018 Aug 14, 2018	BUY	$10.0 - $17.87 $1.15 Million - $2.06 Million	115,000 New	115,000 $1.74 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.